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Results: 41 subjects have completed baseline assessments
and started the training intervention (Age: 65±8 years, BMI:
33.1±6.8kg/m2, Total WOMAC Score: 33±15). Of those, 17
have completed the training intervention. Due to imaging artifact
in the medial compartment, articular cartilage from 14 medial
tibias was segmented. All lateral tibias were included. There was
no significant difference between groups for cartilage thickness
as shown in the table, or any other clinical variables at baseline.
However, medial cartilage volume (P= 0.039) was significantly
lower in the sham group; and lateral denuded area (P=0.02) was
significantly lower in the PRT group at baseline.
Cartilage thickness (P=0.334 MT, P=0.445 LT), volume (P=0.419
MT, P=0.699 LT) and denuded area (P=0.739 MT, P=0.563 LT)
did not change significantly following the training intervention.
Overall strength increased significantly in the PRT group com-
pared to the sham group following the training intervention.
Conclusions: These interim results suggest cartilage thickness,
volume and denuded area were not significantly different be-
tween groups following the training intervention. Overall muscle
strength increased significantly in the PRT group compared to
the sham group over time. Completion of the full complement
of subjects in this ongoing trial will allow further analysis of the
relationship between anabolic exercise and cartilage morphology
in OA.
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OF KNEE OSTEOARTHRITIS PATIENTS IN THE
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Purpose: The GUIDE trial showed the efficacy of the prescrip-
tion glucosamine sulfate formulation on the symptoms of knee
osteoarthritis (Arthritis Rheum 2005;52, 9 Suppl:1203). The aim
of the present study was to assess its effects on Quality of Life
in the GUIDE patient cohort.
Methods: GUIDE was a multicenter, prospective, randomised,
double-blind, parallel-group trial. Patients with knee osteoarthritis
(ACR criteria) received double-dummy oral glucosamine sulfate
soluble powder 1500mg once-a-day, or acetaminophen 1000mg
tablets t.i.d., or placebo for 6 months. Quality of Life was as-
sessed by the SF-36 questionnaire in 296 patients at random-
ization and repeated after 6 months. The primary analysis was
conducted on the changes in the SF-36 Mental Component
Score (MCS, assessing the domains Mental Health, Role Emo-
tional, Social Functioning) and Physical Component Score (PCS,
with domains Bodily Pain, Role Physical, Physical Functioning,
Vitality, General Health, the latter two being included also in the
calculation of the MCS). Changes in each domain were sec-
ondary endpoints. GLM-ANOVA was used with the Dunnet’s test
adjusting for the comparisons of each active vs placebo, in ITT
by the LOCF approach. Effect sizes vs placebo were calculated
as the difference between mean changes standardized on the
pooled SD. The Pearson test assessed the correlation between
the changes in the SF-36 and those in the previously reported
primary (Lequesne index) and secondary (WOMAC index) symp-
tom outcomes in the trial.
P332 – Table 1
Placebo N=96 Acetaminophen N=100 Glucosamine Sulfate N=100
Baseline  6 months Baseline  6 months Baseline  6 months
SF-36 PCS (mean±SD) 33.3±8.3 1.7±10.3 34.2±9.0 4.2±9.1 32.7±9.3 6.7±10.4*
SF-36 MCS (mean±SD) 53.3±11.4 0.7±11.0 50.0±13.2 0.3±11.8 50.9±13.0 0.7±10.6
*P=0.001 vs Placebo: Difference=5.0 (95% CI: 1.9 to 8.2). Effect Size=0.49 (0.20 to 0.77)
Results: Glucosamine sulfate showed an improvement in all
PCS domains of the SF-36, that was significant vs placebo
for Bodily Pain (P=0.014), Role Physical (P=0.006) and Gen-
eral Health (P=0.031). The difference on the aggregate PCS
was therefore highly significant, with a good effect size (Table
1). There were no significant improvements in the MCS, thus
excluding direct psychological effects. Acetaminophen was not
significantly different from placebo in any of the analyses.
There was a highly significant correlation (P<0.01) between the
improvements in the SF-36 PCS and those previously reported
in the Lequesne index (r =0.58) and WOMAC total (r =0.56), pain
(r =0.51) and function (r =0.56) scales, respectively.
Conclusions: Treatment for 6 months with glucosamine sulfate
1500mg once-a-day improves Quality of Life in knee osteoarthri-
tis by favorably affecting the physical components of well-being,
in a way that is highly correlated with its efficacy on pain and
function as assessed by disease specific measures.
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Purpose: Rapidly destructive osteoarthritis of the hip (RDA) is
an uncommon form of hip OA that is seen mostly in elderly
postmenopausal women. Recent discovery of subchondral insuf-
ficiency fracture that precedes destruction of the femoral head
suggests a role for ostopenia during rapid destruction of the hip
joint. The aim of our work was to compare the bone mineral
density (BMD) between patients with rapidly destructive hip OA
(RDA) and slowly progressive hip OA.
Methods: This prospective cross sectional case-control study
was conducted in 26 patients with RDA. Patients were recruited
from our institution between 2000 and 2006. RAD was defined
by the following criteria: severe hip pain; annual rate of joint
space loss >2 mm; erythrocyte sedimentation rate <20 mm/1st
h. MRI of the hip was performed in 15 patients with RDA. Bone
mineral density was measured at the femoral neck and lumbar
spine (L1-L4) using dual-energy X-ray absorptiometry (Hologic).
For comparison, BMD was measured in 33 women with slowly
hip OA who were scheduled for primary total hip arthroplasty.
Comparisons between the two groups of patients were made
using student t test for all variables. Two-sided significance level
was fixed at 5%. All tests were made using SAS software version
9.13 (from SAS Institute).
Results: The patients with rapidly destructive hip OA (80%
women and 20%men) did not differ from control in age (74.9 ±
9.9 vs 74.7 ± 8.8; p=0.92) and BMI (26.3 ± 4.3 vs 26.3 ± 5;
p=0.96). In patients with RDA, mean BMD was 1.0 ±0.2 g/cm2
at the lumbar spine (Tscore: -0.6 ±1.3) and 0.7±0.1 g/cm2 at the
femoral neck (Tscore:-1.5±1.1). In controls, mean BMD was 1.0
±0.2 g/cm2 at the lumbar spine (Tscore: -0.8 ±1.5)(p=0.67) and
0.8±0.2 g/cm2 at the femoral neck (Tscore:-1.4±1.4)(p=0.40).
In three patients (20%), evidence of subchondral insufficiency
fracture was shown on MR imaging.
Conclusions: The results of our study do not support a role for
Osteoarthritis and Cartilage Vol. 14, Supplement B S181
ostopenia in the mechanism of rapidly destructive hip osteoarthri-
tis. We confirm the presence of subchondral insufficiency fracture
in hip with RDA.
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Purpose: Three-dimensional morphologic data of the osteo-
porotic and osteoarthritic spine has not been established.
Methods: We created computerized 3-D renderings of 1160
spines comprised of post-menoposal women aged 45-85, pri-
marily of patients of osteoporosis and osteoarthritis, and healthy
female controls aged 20-40. The digital 3-D models were con-
structed from helical CT data and examined for morphologic
characteristics.
Results: Close examination of the 3-D models revealed that
the vertebral endplates of post-menopausal women are rarely
smooth and are frequently compromised with perforated indenta-
Fig. 1. Perforation to endplate area ratio and years after menopause.
Fig. 2
tions, or Schmorl’s nodes. These could possibly act as openings
through which pressure-induced escape of the disk nucleus
could occur, and suggests that disk herniation into the weakened
vertebral body through the perforated endplates can cause OA-
inducing instability in the same manner as the lateral slippage of
the disk.
We further calculated the ratio of the perforations to the area
of the endplates and found that the there was a significant
correlation between the perforation/endplate area ratio and the
number of years after menopause.
Conclusions: Close examination of 3-D renderings of the os-
teoporotic vertebrae revealed that the vertebral endplates of
post-menopausal women are often compromised with indenta-
tions and perforations whose ratio to the area of the endplates
increase with years after menopause. In at least some of the
cases, the apparent narrowing of the intervertebral space result-
ing in the contact of the vertebral rims and the subsequent OA
changes, in what has conventionally been known as fish-shaped
vertebral fractures, may in fact be secondary to the herniation
of the disk nucleus into the weakened vertebral body of the
osteoporotic spine.
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HYSTERECTOMY AND HRT TREATMENT: AN
ASSOCIATION WITH OSTEOARTHRITIS IN EARLY
POSTMENOPAUSAL WOMEN?
L.A. Walker, R.M. Aspden, D.M. Reid, H.M. Macdonald
University of Aberdeen, Aberdeen, United Kingdom
Purpose: Previous investigations have presented conflicting evi-
dence concerning a potential association between gynaecologic
and reproductive factors and osteoarthritis (OA). Support for a
hormonal association with OA comes from retrospective stud-
ies suggesting that women who have had a surgically induced
menopause have a 2-fold increase for the risk of OA when com-
pared with controls. Conflicting reports from previous studies
have suggested both positive and negative effects of hormone
replacement therapy (HRT) on the incidence of OA following
hysterectomy. The aim of this investigation was to determine
whether self-reported OA is associated with total hysterectomy
and/or HRT use in a large cohort of women.
Methods: Between 1990-1994, 5119 women, aged between
49-54 years (mean 48.5±2.3)) were recruited randomly from a
community health index for the Aberdeen Prospective Osteo-
porosis Screening Study (APOSS). Each was weighed, their
height measured and asked questions relating to bone disease,
menopausal status, hysterectomy, hormone replacement therapy
(HRT), and current smoking. 223 participants self-reported OA
while 4896 did not. Between 1997-2000, 3883 women (mean
age 54.8±2.2) returned for a 2nd visit and underwent similar
investigations. At this visit 687 women self-reported OA.
Results: Women with OA were significantly (p<0.001) heavier at
baseline 68.73±0.53 kg and follow-up 71.80±0.55 kg visits than
those without OA; baseline 65.40±0.23 kg, follow-up 68.00±0.24
kg. Preliminary results indicate that the risk of OA was signifi-
cantly higher among women who had had a hysterectomy or who
had stopped HRT. After adjustment for potential confounding fac-
tors such as age and weight, the odds ratios (95% confidence
intervals) of OA among all hysterectomized women compared
with controls was 1.34 (1.08, 1.66) (p=0.007). For women who
had previously taken HRT but stopped, the odds ratio for re-
porting OA (95% CI) was 1.57 (1.28, 1.95), p=0.01. There was
no increased risk in current HRT users, OR:1.13 (0.93, 1.39),
p=0.22.
Conclusions: In this population, a hysterectomy or ceasing
HRT treatment was associated with an increase in self-reported
OA. However, whether these factors are directly involved in the
